Moleukulare Ursachen von Entwicklungsstörungen des Endokriniums

  • Annette Grüters
Part of the Molekulare Medizin book series (MOLMED)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

4.2.9 Literatur

  1. Abramowicz MJ, Duprez L, Parma J et al. (1997) Familial congenital hypothyroidism due to inactivating mutations of the TSH receptor gene causing profound thyroid hypoplasia. J Clin Invest 99:3018–3024PubMedCrossRefGoogle Scholar
  2. Achermann JC, Meeks JJ, Jameson JL (2001) Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol Dec 20; 185(l/2):17–25PubMedCrossRefGoogle Scholar
  3. Achermann JC, Ito M, Hindmarsh PC, et al (1999) A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125–126PubMedCrossRefGoogle Scholar
  4. Achermann JC, Ozisik G, Ito M, et al (2002) Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocr Metab 87:1829–1833PubMedCrossRefGoogle Scholar
  5. Achermann JC, Silverman BL, Habiby RL, et al (2000) Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1. J Pediat 137:878–881PubMedCrossRefGoogle Scholar
  6. Aittomaki K, Lucena JL, Pakarinen P, et al (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82: 959–968CrossRefPubMedGoogle Scholar
  7. Allgrove J, Clayden GS, Grant DB, et al (1978) Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1:1284–1286PubMedCrossRefGoogle Scholar
  8. Ambrugger P, Stoeva I, Biebermann H, et al (2001) Novel mutations of the TPO gene in patients with permanent congenital hypothyroidism. Eur J Endocrin 145:19–24CrossRefGoogle Scholar
  9. Auchus RJ, Miller WL (1999) Molecular modeling of human P450cl7 (17-alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13:1169–1182CrossRefPubMedGoogle Scholar
  10. Barbosa AS, Hadjiathanasiou CG, Theodoridis C, et al (1999) The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms’ tumor. Hum Mutat 13:146–153CrossRefPubMedGoogle Scholar
  11. Beranova M, Oliveira LM, Bedecarrats GY, et al (2001) Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocr Metab 86:1580–1588CrossRefPubMedGoogle Scholar
  12. Biason-Lauber A, Schoenle EJ (2000) Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67:1563–1568CrossRefPubMedGoogle Scholar
  13. Biebermann H, Schöneberg T, Krude H, et al (1995) Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and congenital hypothyroidism. J Clin Endocrin Metab 82:3471–3480CrossRefGoogle Scholar
  14. Biebermann H, Schöneberg T, Krude H, et al (1997) Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 82:3471–3480CrossRefPubMedGoogle Scholar
  15. Bione S, Sala C, Manzini C, et al (1998) A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 62:533–541CrossRefPubMedGoogle Scholar
  16. Bishop CE, Whitworth DJ, Qin Y, et al (2000) A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet 26:490–494CrossRefPubMedGoogle Scholar
  17. Bland ML, Jamieson CA, Akana SF, et al (2000) Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Nat Acad Sci 97:14488–14493PubMedCrossRefGoogle Scholar
  18. Bose HS, Sato S, Aisenberg J, et al (2000) Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocr Metab 85:3636–3639CrossRefPubMedGoogle Scholar
  19. Brickman JM, Clements M, Tyrell R, et al (2001) Molecular effects of novel mutations in Hesxl/HESXl associated with human pituitary disorders. Development 128:5189–5199PubMedGoogle Scholar
  20. Brinkmann AO (2001) Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179:105–109CrossRefPubMedGoogle Scholar
  21. Bruening W, Bardeesy N, Silverman BL, et al (1992) Germline intronic and exonic mutations in the Wilms’ tumour gene (WT1) affecting urogenital development. Nat Genet 1:144–148CrossRefPubMedGoogle Scholar
  22. Brumm H, Pfeufer A, Biebermann H, et al (2002) Congenital central hypothyroidism due to homozygous thyrotropin beta 313-delta-T mutation is caused by a founder effect. J Clin Endocr Metab 87:4811–4816CrossRefPubMedGoogle Scholar
  23. Canto P, Escudero I, Soderlund D, et al (2003) A novel mutation of the insulin-like 3 gene in patients with cryptorchidism. J Hum Genet 48:86–90CrossRefPubMedGoogle Scholar
  24. Clark AJ, McLoughlin L, Grossman A (1993) Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341:461–462PubMedCrossRefGoogle Scholar
  25. Clifton-Bligh RJ, Wentworth J, Heinz P, et al (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nature Genetics 18:399–401Google Scholar
  26. Clipsham R, McCabe ER (2003) DAX1 and its network partners: exploring complexity in development. Mol Genet Metab 80:81–120CrossRefPubMedGoogle Scholar
  27. Collu R, Tang J, Castagne J, et al (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocr Metab 82:1361–1365CrossRefGoogle Scholar
  28. Curnow KM, Slutsker L, Vitek J, et al (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Nat Acad Sci 90:4552–4556PubMedCrossRefGoogle Scholar
  29. Dattani MT, Martinez-Barbera J-P, Thomas PQ, et al (1998) Mutations in the homeobox gene HESXl/Hesxl associated with septooptic dysplasia in human and mouse. Nature Genet 19:125–130CrossRefPubMedGoogle Scholar
  30. De Feiice M, Ovitt C, Biffali E, et al (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 19:395–398CrossRefGoogle Scholar
  31. De Zegher F, Jaeken J (1995) Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. Pediatr Res 87:395–401Google Scholar
  32. Dode C, Levilliers J, Dupont J-M, et al (2003) Loss-offunction mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nature Genet 33:463–465PubMedCrossRefGoogle Scholar
  33. Doherty E, Pakarinen P, Tiitinen A, et al (2002) A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocr Metab 87:1151–1155CrossRefPubMedGoogle Scholar
  34. Finnish-German APECED Consortium (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17:399–403CrossRefGoogle Scholar
  35. Genin E, Huebner A, Jaillard C, et al (2002) Linkage of one gene for familial glucocortieoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity. Hum Genet 111:428–434PubMedCrossRefGoogle Scholar
  36. Georgopoulos NA, Pralong FP, Seidman CE, et al (1997) Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocr Metab 82:213–217CrossRefPubMedGoogle Scholar
  37. Gromoll J, Eiholzer U, Nieschlag E, et al (2000) Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocr Metab 85:2281–2286CrossRefPubMedGoogle Scholar
  38. Handschug K, Sperling S, Yoon SJ, et al (2001) Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Molec Genet 10:283–290PubMedCrossRefGoogle Scholar
  39. Jager RJ, Anvret M, Hall K, et al (1990) A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 348:452–454PubMedCrossRefGoogle Scholar
  40. Jameson JL, Achermann JC, Ozisik G, et al (2003) Battle of the sexes: new insights into genetic pathways of gonadal development. Trans Am Clin Climatol Assoc 114:51–63PubMedGoogle Scholar
  41. Kim S, Hebrok M (2001) Intracellular signals regulating pancreas development and function. Gene Dev 15:111–127CrossRefPubMedGoogle Scholar
  42. Kim SK, Selleri L, Lee JS, et al (2002) Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat Genet 30:430–435CrossRefPubMedGoogle Scholar
  43. Kimura S, Hara Y, Pineau T, et al (1996) The T/ebp null mouse: thyroid-specifie enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10:60–69PubMedCrossRefGoogle Scholar
  44. Koopman P, Gubbay J, Vivian N, et al (1991) Male development of chromosomally female mice transgenic for Sry. Nature 351:117–121CrossRefPubMedGoogle Scholar
  45. Kremer H, Kraaij R, Toledo SP, et al (1995) Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160–164CrossRefPubMedGoogle Scholar
  46. Krude H, Schuetz B, Biebermann H, et al (2002) Choreotetosis, hypothyroidism and pulmonary problems due to NKX2.1 haploinsufficiency. J Clin Invest 109:475–480CrossRefPubMedGoogle Scholar
  47. Krude H, Biebermann H, Luck W, et al (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genet 19:155–157CrossRefPubMedGoogle Scholar
  48. Kumagai J, Hsu SY, Matsumi H, et al (2002) INSL3/leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277:31283–31286CrossRefPubMedGoogle Scholar
  49. Kyllo LH, Collins MM, Vetter KL, et al (1996) Linkage of congenital isolated adrenocorticotropic hormone deficiency to the corticotropin releasing hormone locus using simple sequence repeat polymorphisms. Am J Med Genet 62:262–267CrossRefPubMedGoogle Scholar
  50. Lamolet B, Pulichino AM, Lamonerie T, et al (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849–859CrossRefPubMedGoogle Scholar
  51. Lawoko-Kerali G, Rivolta MN, Holley M (2002) Expression of the transcription factors GATA3 and Pax2 during development of the mammalian inner ear. J Comp Neurol 442:378–391CrossRefPubMedGoogle Scholar
  52. Layman LC, Lee E-J, Peak DB, et al (1997) Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. New Eng J Med 337:607–611PubMedCrossRefGoogle Scholar
  53. Layman LC, Cohen DP, Jin M, et al (1998) Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nature Genet 18:14–15CrossRefPubMedGoogle Scholar
  54. Lin D, Sugawara T, Strauss JF III, et al (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828–1831PubMedCrossRefGoogle Scholar
  55. Lin SC, Lin CR, Gukovsky I, et al (1993) Molecular basis of the little mouse phenotype and implications for cell type-specifie growth. Nature 364:208–213CrossRefPubMedGoogle Scholar
  56. Lindsay EA, Vitelli F, Su H, et al (2001) Tbxl haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97–101CrossRefPubMedGoogle Scholar
  57. Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9:209–225CrossRefPubMedGoogle Scholar
  58. Macchia PE, Lapi P, Krude H, et al (1998) PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nature Genetics 19:83–86PubMedCrossRefGoogle Scholar
  59. Machinis K, Pantel J, Netchine I, et al (2001) Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 69:961–968CrossRefPubMedGoogle Scholar
  60. Mansouri A, Chowdhury K, Gruss P (1998) Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 19:87–90PubMedCrossRefGoogle Scholar
  61. Matthews CH, Borgato S, Beck-Peccoz P, et al (1993) Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nature Genet 5:83–86CrossRefPubMedGoogle Scholar
  62. Meeks JJ, Weiss J, Jameson JL (2003) Daxl is required for testis determination. Nat Genet 34:32–33CrossRefPubMedGoogle Scholar
  63. Merscher S, Funke B, Epstein JA, et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619–629CrossRefPubMedGoogle Scholar
  64. Morais da Silva S, Hacker A, Harley V, et al (1996) Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 14:62–68CrossRefGoogle Scholar
  65. Morel Y, Rey R, Teinturier C, et al (2002) Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 161:49–59PubMedGoogle Scholar
  66. Moreno JC, Bikker H, Kempers MJ, et al (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. New Eng J Med 347:95–102PubMedCrossRefGoogle Scholar
  67. Netchine I, Sobrier M-L, Krude H, et al (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genet 25:182–186PubMedCrossRefGoogle Scholar
  68. Nordenstrom A, Thilen A, Hagenfeldt L, et al (1999) Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocr Metab 84: 1505–1509PubMedCrossRefGoogle Scholar
  69. Osorio MG, Marui S, Jorge AA, et al (2002) Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. J Clin Endocr Metab 87:5076–5084CrossRefPubMedGoogle Scholar
  70. Pandolfi PP, Roth ME, Karis A, et al (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nature Genet 11:40–44CrossRefPubMedGoogle Scholar
  71. Parvari R, Hershkovitz E, Grossman N, et al (2002) Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat Genet 32:448–452CrossRefPubMedGoogle Scholar
  72. Pelletier J, Bruening W, Kashtan CE, et al (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Dennys-Drash syndrome. Cell 67:437–447CrossRefPubMedGoogle Scholar
  73. Peter M, Viemann M, Partsch C-J, et al (1998) Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J Clin Endocr Metab 83:2666–2674CrossRefPubMedGoogle Scholar
  74. Phillips JA III, Cogan JD (1994) Genetic basis of endocrine disease 6: molecular basis of familial human growth hormone deficiency. J Clin Endocr Metab 78:11–16CrossRefPubMedGoogle Scholar
  75. Radovick S, Nations M, Du Y, et al (1992) A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115–1118PubMedCrossRefGoogle Scholar
  76. Rheaume E, Simard J, Morel Y, et al (1992) Congenital adrenal hyperplasia due to point mutations in the type II 3-beta-hydroxysteroid dehydrogenase gene. Nat Genet 1: 239–245PubMedCrossRefGoogle Scholar
  77. Sala C, Arrigo G, Torri G, et al (1997) Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics 40:123–131CrossRefPubMedGoogle Scholar
  78. Schlessinger D, Herrera L, Crisponi L, et al (2002) Genes and translocations involved in POF. Am J Med Gen 111: 328–333CrossRefGoogle Scholar
  79. Scott HS, Heino M, Peterson P, et al (1998) Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol 12:1112–1119PubMedCrossRefGoogle Scholar
  80. Seminara SB, Messager S, Chatzidaki EE, et al (2003) The GPR54 gene as a regulator of puberty. New Eng J Med 349:1614–1627PubMedCrossRefGoogle Scholar
  81. Sheng HZ, Moriyama K, Yamashita T, et al (1997) Multistep control of pituitary organogenesis. Science 278:1809–1812CrossRefPubMedGoogle Scholar
  82. Speiser PW, Dupont J, Zhu D, et al (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584–595PubMedCrossRefGoogle Scholar
  83. Stalmans I, Lambrechts D, De Smet F, et al (2003) VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med 9:173–182CrossRefPubMedGoogle Scholar
  84. Stein SA, Oates EL, Hall CR, et al (1994) Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 8:129–138CrossRefPubMedGoogle Scholar
  85. Stoffers DA, Zinkin NT, Stanojevic V, et al (1997) Pancreatic agenesis attributable to a Single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15: 106–110CrossRefPubMedGoogle Scholar
  86. Stuhrmann M, Heilbronner H, Reis A, et al (1991) Characterisation of a Xp21 microdeletion syndrome in a 2-year-old boy with muscular dystrophy, glycerol kinase deficiency and adrenal hypoplasia congenita. Hum Genet 86:414–415CrossRefPubMedGoogle Scholar
  87. Tajima T, Fujieda K, Kouda N, et al (2001) Heterozygous mutation in the cholesterol side chain cleavage enzyme (P450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocr Metab 86:3820–3825CrossRefPubMedGoogle Scholar
  88. Thaler JP, Lee S-K, Jurata LW, et al (2002) LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions. Cell 110:237–249CrossRefPubMedGoogle Scholar
  89. Van Esch H, Groenen P, Nesbit MA, et al (2000) GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406:419–422PubMedCrossRefGoogle Scholar
  90. Wagner T, Wirth J, Meyer J, et al (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111–1120CrossRefPubMedGoogle Scholar
  91. Wajnrajch MP, Gertner JM, Harbison MD, et al (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 12:88–90CrossRefPubMedGoogle Scholar
  92. Weiss J, Axelrod L, Whitcomb RW, et al (1992) Hypogonadism caused by a Single amino acid Substitution in the beta subunit of luteinizing hormone. New Eng J Med 326:179–183PubMedGoogle Scholar
  93. Westphal H (2003) Genes that fashion the pituitary gland. Mol Cell Endocrinol 29/197:45–46Google Scholar
  94. White PC, Dupont J, New MI, et al (1991) A mutation in CYP11B1 (arg448-to-his) associated with steroid 11-beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 87:1664–1667PubMedCrossRefGoogle Scholar
  95. Wolfe A, Kim HH, Tobet S, et al (2002) Identification of a discrete promoter region of the human GnRH gene that is sufficient for directing neuron-specific expression: a role for POU homeodomain transcription factors. Mol Endocrinol 16:435–449CrossRefPubMedGoogle Scholar
  96. Wu S-M, Hallermeier KM, Laue L, et al (1998) Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12:1651–1660PubMedCrossRefGoogle Scholar
  97. Wu W, Cogan JD, Pfaffle RW, et al (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genet 18:147–149CrossRefPubMedGoogle Scholar
  98. Yagi H, Furutani Y, Hamada H, et al (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366–1373CrossRefPubMedGoogle Scholar
  99. Zanaria E, Muscatelli F, Bardoni B, et al (1994) An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635–641CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Annette Grüters
    • 1
  1. 1.Campus Virchow-Klinikum, Humboldt-Universität zu Berlin, Pädiatrische Endokrinologie, Allgemeine Poliklinik, Otto-Heubner-Centrum für Kinder- und JugendmedizinCharité — Universitätsmedizin BerlinBerlin

Personalised recommendations